TG Therapeutics: Entering 2025 With Increased Investor Expectations

Group 1 - TG Therapeutics, Inc. (NASDAQ: TGTX) presented at the JP Morgan Healthcare Conference, where CEO Michael Weiss discussed the company's accomplishments in 2024 and provided updates on its progress [2] - The company is part of the Growth Stock Forum, which features a model portfolio of 15-20 stocks, a top picks list of up to 10 stocks expected to perform well, and trading ideas targeting short-term and medium-term moves [2] Group 2 - The article reflects the author's opinion and does not constitute a buy or sell recommendation or investment advice [3][4]